London pre-open: Stocks set for lower start after EU elections
10th Jun 2024 06:25
(Sharecast News) - Stocks in London look primed for a lower start as investors digest the gains made by far right parties in Austria, Germany, but above all France, at the European Union elections that were held at the weekend.
Read moreAstraZeneca's lung cancer treatment recommended for approval in EU
3rd Jun 2024 07:28
(Sharecast News) - AstraZeneca has announced that its Tagrisso treatment for advanced lung cancer, when combined with chemotherapy, has been recommended for approval by European regulators.
Read moreAstraZeneca experimental lung cancer drug shows promising results
28th May 2024 07:02
(Sharecast News) - AstraZeneca's experimental lung cancer drug showed improved overall survival rates in phase III trials, the pharmaceutical giant said on Tuesday.
Read moreSector movers: Stocks slip amid light profit-taking
21st May 2024 19:00
(Sharecast News) - Stocks ended a tad lower as investors waited on a raft of US central bank speakers scheduled for after the close of markets in London.
Read moreLondon close: Stocks fall ahead of key inflation reading
21st May 2024 15:00
(Sharecast News) - London stocks ended in negative territory on Tuesday, influenced by the latest UK economic outlook from the International Monetary Fund (IMF) and comments from US Federal Reserve officials.
Read moreAstraZeneca lays out plans to hit $80bn in revenues by 2030
21st May 2024 07:34
(Sharecast News) - AstraZeneca has unveiled medium-term growth targets to nearly double group revenues by the end of the decade as it predicts significant growth from existing oncology, biopharmaceuticals and rare disease portfolios.
Read moreAstraZeneca announces $1.5bn Singapore manufacturing facility
20th May 2024 07:22
(Sharecast News) - AstraZeneca announced plans to construct a $1.5bn manufacturing facility in Singapore on Monday, dedicated to the production of antibody drug conjugates (ADCs).
Read moreSector movers: Aerospace and Defence, Pharma pace gains
8th May 2024 19:10
(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.
Read moreLondon close: Stocks rise further ahead of BoE decision
8th May 2024 16:36
(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.
Read moreBerenberg hikes target price on Astrazeneca
7th May 2024 15:54
(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".
Read moreAstraZeneca reports positive results from blood cancer drug trial
2nd May 2024 07:45
(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.
Read moreAstraZeneca makes progress with two breast cancer treatments
29th Apr 2024 07:24
(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.
Read moreLondon close: Stocks finish mixed as US GDP growth slows
25th Apr 2024 15:14
(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.
Read moreAstraZeneca blows past analysts' estimates for Q1
25th Apr 2024 08:38
(Sharecast News) - AstraZeneca posted better-than-expected revenues and profit for the first quarter of 2024 with both the company and analysts highlighting its drug pipeline.
Read moreLondon close: Stocks finish lower as ECB stands pat
11th Apr 2024 15:56
(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.
Read more